<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01491867</url>
  </required_header>
  <id_info>
    <org_study_id>4481/2011</org_study_id>
    <nct_id>NCT01491867</nct_id>
  </id_info>
  <brief_title>Continuous Intraocular Pressure (IOP) Measurement and Ability to Detect Treatment Effect</brief_title>
  <official_title>Evaluation of Continuous IOP Measurement and the Influence of Drug Induced IOP Decrease on the Measurement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Semmelweis University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Semmelweis University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Continuous intraocular pressure (IOP) measurement with a contact lens sensor may provide more
      information on the drug-related IOP change than 24-hour IOP measurement with Goldmann
      applanation tonometry (GAT.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Participants are washed ot from all glaucoma medication for 6 weeks

        -  one eye per participant is investigated (study eye)

        -  24-h intraocular pressure (IOP) curve is obtained with Goldmann tonometry and Sensimed
           contact lens sensor tonometry twice, in 14 days

        -  for Sensimed contact lens curves median values (in arbitrary units), for Goldmann
           applanation tonometry, mean and SD values are used to characterize the curves, for
           comparisions % changes are used for the corresponding time periods

        -  treatment (travoprost 0.005% 1/day) is given to all eyes for 3 months 24-h Goldmann and
           Sensimed IOP curves are repeated

        -  IOP curves are determined in arbitrary units and mmHg, respectively, and compared for
           reproducibility (untreated phase) and relative (%)change (untreated curve vs. under
           treatment curve) with both methods, respectively
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Continuous intraocular pressure (IOP) measurement</measure>
    <time_frame>3 months</time_frame>
    <description>24-h intraocular pressure (IOP) decrease induced by travoprost 0.003% 1/day as measured with Goldmann tonometry and Sensimed contact lens sensor</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Continuous intraocula pressure (IOP) Measurement</measure>
    <time_frame>3 months</time_frame>
    <description>Reproducibility of intraocular pressure measurements with the Sensimed contact lens sensor methods</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Glaucoma</condition>
  <condition>Ocular Hypertension</condition>
  <arm_group>
    <arm_group_label>Travoprost arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All individuals receive travoprost 0.003% 1/day in both eyes after 6 weeks wash-out for 3 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>travoprost 0.003%</intervention_name>
    <description>Instillation of travoprost 0.003% 1/die in both eyes for 3 months</description>
    <arm_group_label>Travoprost arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  primary open-angle glaucoma (POAG), ocular hypertension(OHT)

          -  18 years or older

          -  C/D &lt;= 0.7

          -  no risk for visual field damage

          -  IOP &gt; 22 mmHg

        Exclusion Criteria:

          -  Pregnancy and lactation

          -  Known intolerance to travoprost, topical anesthetic

          -  Previous ocular surgery at any time

          -  Previous ocular laser treatment within 1 year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gabor Hollo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Semmelweis University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Departement of Ophthalmology</name>
      <address>
        <city>Budapest</city>
        <state>Pest</state>
        <zip>1083</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Semmelweis University</name>
      <address>
        <city>Budapest</city>
        <zip>1083</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2011</study_first_submitted>
  <study_first_submitted_qc>December 13, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2011</study_first_posted>
  <last_update_submitted>March 20, 2013</last_update_submitted>
  <last_update_submitted_qc>March 20, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 22, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Semmelweis University</investigator_affiliation>
    <investigator_full_name>Gabor Hollo</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <keyword>intraocular pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ocular Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Travoprost</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

